FDA Approves MiniMed 770G Closed Loop Hybrid System

MiniMed 770G System - P160017/S076

The Medtronic MiniMed 770G System is the first FDA-approved hybrid closed-loop system that monitors glucose and automatically adjusts the delivery of long-acting or basal insulin based on the user’s glucose reading in users two years and up. An earlier version of this device (MiniMed 670G System, without the Bluetooth capability) was previously approved only for users aged seven years and up.

The Medtronic MiniMed 770G System consists of a continuous glucose monitor (CGM) that measures the user’s glucose levels for up to seven days, an insulin pump that delivers insulin to the user, and a glucose meter used to calibrate the CGM.

Minimed 770G

Read more on the FDA website here.